Salvage chemotherapy With CPT-11 for recurrent meningioma

被引：0
|
作者：
Marc C. Chamberlain
Denice D. Tsao-Wei
Susan Groshen
机构：
[1] Moffitt Cancer Center and Research Institute,Department of Interdisciplinary Oncology
[2] USC/Norris Cancer Center,Department of Preventive Medicine
来源：
Journal of Neuro-Oncology | 2006年 / 78卷
关键词：
CPT-11; meningioma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：271 / 276
页数：5
相关论文
共 50 条
  • [41] INTRACELLULAR ROLES OF SN-38, A METABOLITE OF THE CAMPTOTHECIN DERIVATIVE CPT-11, IN THE ANTITUMOR EFFECT OF CPT-11
    KAWATO, Y
    AONUMA, M
    HIROTA, Y
    KUGA, H
    SATO, K
    CANCER RESEARCH, 1991, 51 (16) : 4187 - 4191
  • [42] Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11)
    Chen, Shujuan
    Yueh, Mei-Fei
    Bigo, Cyril
    Barbier, Olivier
    Wang, Kepeng
    Karin, Michael
    Nghia Nguyen
    Tukey, Robert H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (47) : 19143 - 19148
  • [43] METRONOMIC CPT-11 CHEMOTHERAPY COMBINED WITH ULTRASOUND IRRADIATIO FOR A HUMAN UTERINE SARCOMA XENOGRAFT
    Choijamts, B.
    Emoto, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [44] Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer - Discussion
    Velanovich, V
    Newman, E
    Kelly, K
    Zenilman, M
    Fink, V
    Pellegrini, C
    JOURNAL OF GASTROINTESTINAL SURGERY, 2002, 6 (02) : 223 - 223
  • [45] Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer
    Tatsuru Ohara
    Yoichi Kobayashi
    Ayako Yoshida
    Norihito Yoshioka
    Namiko Yahagi
    Haruhiro Kondo
    Akiko Tozawa
    Kazushige Kiguchi
    Nao Suzuki
    International Journal of Clinical Oncology, 2013, 18 : 1102 - 1106
  • [46] Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer
    Ohara, Tatsuru
    Kobayashi, Yoichi
    Yoshida, Ayako
    Yoshioka, Norihito
    Yahagi, Namiko
    Kondo, Haruhiro
    Tozawa, Akiko
    Kiguchi, Kazushige
    Suzuki, Nao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1102 - 1106
  • [47] Investigation of interaction between CPT-11 and bilirubin
    Kato, Ryuji
    Sadamatsu, Maiko
    Nishide, Mami
    Marikawa, Risa
    Sasaki, Daisuke
    Kadobayashi, Takaaki
    Kobayashi, Toyohide
    Urashima, Kazuya
    Ijiri, Yoshio
    Tanaka, Kazuhiko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 : 49 - 49
  • [48] Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer
    Sugiyama, T
    Yakushiji, M
    Kamura, T
    Ikeda, M
    Umesaki, N
    Hasegawa, K
    Ishikawa, M
    Saji, F
    Hiura, M
    Takahashi, T
    Sato, S
    Ochiai, K
    Kikkawa, F
    Takeuchi, S
    Ohashi, Y
    Noda, K
    ONCOLOGY, 2002, 63 (01) : 16 - 22
  • [49] CPT-11 approved, oxaliplatin rejected by FDA
    不详
    ANNALS OF ONCOLOGY, 2000, 11 (06) : 640 - 640
  • [50] CPT-11: An original spectrum of clinical activity
    Rothenberg, ML
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 21 - 26
12345